Hospital Acquired Infections (HAI) Diagnostics Market Revenue, Growth, Restraints, Trends, Company Profiles, Analysis &a

Comments · 592 Views

global Hospital Acquired Infections (HAI) Diagnostics market is forecast to reach USD 5.68 Billion by 2027, according to a new report by Reports and Data

 

 

The elevating incidence rate of hospital-acquired infections across the globe and the growing number of researches on infectious disease diagnosis is driving the demand for the market.

The global Hospital Acquired Infections (HAI) Diagnostics market is forecast to reach USD 5.68 Billion by 2027, according to a new report by Reports and Data. The market is growing due to the rise in the number of HAIs or hospital-acquired infections, and growth in the incidence of contagious virus-related diseases. The technological advancement and increasing awareness among the public have led to an increase in the number of surgical operations, which in turn is augmenting the demand for the industry.

Immediate diagnosis of infectious disease is the present need of the time due to evolving pathogens and increasing the occurrence rate of hospital-acquired infections. The government of various nations has been emphasizing on rapid diagnosis of infectious disease as a strategic priority like in the U.S. The global COVID-19 pandemic is another mentionable crucial factor that is boosting the demand for laboratory-based molecular testing capacity and reagents.

The global pharma healthcare market revenue growth is mainly driven by factors such as increasing research development activities in the healthcare sector, rapid adoption of digital technologies, growing demand for advanced point-of-care diagnostics, and rising trends of telehealth and telemedicine. The COVID-19 pandemic has led to acute healthcare supply shortage, and rapid spread of the SARS-CoV-2 infection and rising government initiatives to develop COVID-19 vaccines have further driven market revenue growth.

To get a sample copy of the report, click on @ https://www.reportsanddata.com/sample-enquiry-form/3478

Top companies profiled in the report:

 

Abbott Laboratories, Roche AG, bioMérieux, Alere, Inc., Becton Dickenson, Siemens Healthcare, Thermo Fisher Scientific, Cepheid Inc., Qiagen, and Seegene, Inc., among others.

Global Hospital Acquired Infections (HAI) Diagnostics Market: Regional Outlook

  • North America
    • S.
    • Canada
  • Europe
    • K.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Peru
    • Mexico
    • Rest of Latin America
  • Middle East Africa
    • Saudi Arabia
    • South Africa
    • A.E
    • Rest of Middle East Africa

Global Hospital Acquired Infections (HAI) Diagnostics Market Segmentation:

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Consumables
  • Instruments and Reagents

Test Type Outlook (Revenue, USD Billion; 2017-2027)

  • Urinalysis
  • Molecular Diagnostic
  • Immunoassay

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Drug Resistance Testing
  • Disease Testing

Infection Type Outlook (Revenue, USD Billion; 2017-2027)

  • Bloodstream Infections
  • Gastrointestinal Infections
  • Hospital-Acquired Pneumonia
  • Surgical Site Infections
  • Urinary Tract Infections (UTI)
  • Others

End Users Outlook (Revenue, USD Billion; 2017-2027)

  • Clinics
  • Hospitals
  • Ambulatory Surgery Centers (ASC)
  • Others

To get a Order on the report, click on: @ https://www.reportsanddata.com/report-pricing/3478

Further key findings from the report suggest

  • Urinalysis testing procedure is used to detect as well as manage a various range of disorders, such as kidney diseases, urinary tract infections, and diabetes. It involves checking the concentration, appearance, and content of the urine. It may result in illness or diseases.
  • Gastrointestinal infections is among the most commonly encountered infections in primary care. They are not always severe and can often be resolved quickly. They can be serious inpatient populations and healthcare settings.
  • Among applications, disease testing in HAI diagnostic is anticipated to witness a higher growth rate during the forecast period. Due to the advancement in technology in the healthcare sector, many modern diagnostic instruments and techniques have made the process more accurate.
  • North America held the largest market share throughout the forecast period. The region is anticipated to witness several growth opportunities leading to the increase in the level of awareness among consumers owing to the presence of a large number of educational institutes, hospitals, corporate buildings, and also rise in the self-hygiene among people, which will significantly influence the growth of the industry.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3478

Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.

 About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

 

 

 

 

 

Comments